We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+8.06%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$466B
AUM Growth
+$31.1B
Cap. Flow
+$1.46B
Cap. Flow %
0.31%
Top 10 Hldgs %
18.55%
Holding
6,313
New
443
Increased
2,419
Reduced
2,272
Closed
593

Sector Composition

Rank Sector Weight
1 Technology 17.24%
2 Financials 8.33%
3 Healthcare 8.04%
4 Consumer Discretionary 7.57%
5 Industrials 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLAMW
5401
DELISTED
Slam Corp. warrant
SLAMW
$22.7K ﹤0.01%
119,321
DWSN icon
5402
Dawson Geophysical
DWSN
$145M
$21.9K ﹤0.01%
10,784
-4
-0% -$8
FBRX icon
5403
Forte Biosciences
FBRX
$1.57B
$21.7K ﹤0.01%
833
+8
+1% +$208
ARAV
5404
DELISTED
Aravive, Inc. Common Stock
ARAV
$21.2K ﹤0.01%
16,809
-44,069
-72% -$71.5K
TWLVW
5405
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$21.1K ﹤0.01%
364,180
CRDL
5406
Cardiol Therapeutics
CRDL
$146M
$20.9K ﹤0.01%
23,500
-1,100
-4% -$726
NIR
5407
DELISTED
Near Intelligence, Inc. Common Stock
NIR
$20.7K ﹤0.01%
+14,773
New +$35.2K
TMC icon
5408
TMC The Metals Company
TMC
$1.54B
$20.5K ﹤0.01%
12,600
IGC icon
5409
IGC Pharma
IGC
$26M
$20.4K ﹤0.01%
65,513
+10
+0% +$3
MNTS icon
5410
Momentus
MNTS
$76.3M
$20.2K ﹤0.01%
5
+4
+400% +$18.8K
ADTH
5411
DELISTED
AdTheorent Holding Co
ADTH
$20.1K ﹤0.01%
+14,383
New +$21.9K
MTEM
5412
DELISTED
Molecular Templates, Inc.
MTEM
$20K ﹤0.01%
2,778
+99
+4% +$677
ATTO
5413
DELISTED
Atento S.A.
ATTO
$19.5K ﹤0.01%
19,493
UTAAW
5414
DELISTED
UTA Acquisition Corporation Warrants
UTAAW
$19.5K ﹤0.01%
275,776
BMTX.WS
5415
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
$19.3K ﹤0.01%
128,625
EVLVW
5416
DELISTED
Evolv Technologies Warrant
EVLVW
$19.2K ﹤0.01%
14,039
TIL icon
5417
Instil Bio
TIL
$48.3M
$19.1K ﹤0.01%
1,732
-20,106
-92% -$246K
CTOS.WS
5418
DELISTED
Custom Truck One Source, Inc. Warrants, exerciseable for Common Stock
CTOS.WS
$18.4K ﹤0.01%
73,720
HUBCW icon
5419
Hub Cyber Security Warrant 2/27/28
HUBCW
$175K
$18.4K ﹤0.01%
461,458
SPPI
5420
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$18.3K ﹤0.01%
19,106
-320
-2% -$316
BENFW icon
5421
Beneficient Warrant
BENFW
$177K
$18K ﹤0.01%
+379,725
New +$25.4K
CTMX icon
5422
CytomX Therapeutics
CTMX
$675M
$17.6K ﹤0.01%
10,217
-3,180
-24% -$5.28K
TRCA.WS
5423
DELISTED
Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TRCA.WS
$16.9K ﹤0.01%
309,716
AKBA icon
5424
Akebia Therapeutics
AKBA
$354M
$16.7K ﹤0.01%
18,273
-49,571
-73% -$47.8K
RRAC.WS
5425
DELISTED
Rigel Resource Acquisition Corp Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RRAC.WS
$16K ﹤0.01%
176,403

Similar funds

Goldman Sachs's Q2 2023 Portfolio in Review

As of Q2 2023, Goldman Sachs held 6,313 positions worth $466B, up 7.1% from $435B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Goldman Sachs's Q2 2023 filing shows 443 new, 2,419 increased, 2,272 reduced and 593 closed positions. Its largest new stake was Pelagos Insurance Capital: 15,246,144 shares worth $208M. The largest sale was Invesco QQQ Trust, an estimated $1.14B.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Goldman Sachs's largest Q2 2023 buy was Pelagos Insurance Capital: 15,246,144 shares worth $208M.
  • Goldman Sachs added most to Alphabet (Google) Class A in Q2 2023, an estimated $884M increase.
  • Goldman Sachs's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.14B.
  • Goldman Sachs fully exited DCP Midstream, LP in Q2 2023, selling an estimated $250M.
  • Goldman Sachs's ten largest holdings make up 19% of its $466B portfolio in Q2 2023.
  • Goldman Sachs opened 443 new positions and closed 593 in Q2 2023.
  • Goldman Sachs's portfolio value rose 7.1% quarter-over-quarter to $466B.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.